Pharmabiz

Medidata expands partnership with Menarini Group; deploying Medidata’s study to build AI technology to speed up global oncology pipeline

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced a strategic expansion of its partnership with The Menarini Group (Menarini ...
Pharmabiz

WHO recommends near point-of-care tests, tongue swabs, and sputum pooling for TB diagnosis

WHO recommends near point-of-care tests, tongue swabs, and sputum pooling for TB diagnosis: Geneva Wednesday, March 11, 2026, 14:00 Hrs [IST] The World Health Organization (WHO) i ...
Pharmabiz

Hutchmed announces update on licensed oncology product Tazverik in China

Hutchmed announces update on licensed oncology product Tazverik in China: Hong Kong, Shanghai Wednesday, March 11, 2026, 15:00 Hrs [IST] Hutchmed (China) Limited, an innovative, c ...
Pharmabiz

SC asks Centre to create a no-fault compensation policy for SAEs from Covid-19 vaccines

The Supreme Court of India has asked the Central government to frame a no-fault compensation policy for serious adverse events resulting from Covid-19 vaccination. The Court also observed that ...
Pharmabiz

US FDA grants 510(k) clearance to GE HealthCare’s View, a next generation diagnostic viewer enabling anywhere access to radiologists

US FDA grants 510(k) clearance to GE HealthCare’s View, a next generation diagnostic viewer enabling anywhere access to radiologists: Chicago Wednesday, March 11, 2026, 12:00 Hr ...
Pharmabiz

Medtronic to acquire Salt Lake City, Utah-based private company, Scientia Vascular for $550 million

Medtronic to acquire Salt Lake City, Utah-based private company, Scientia Vascular for $550 million: Galway, Ireland Wednesday, March 11, 2026, 11:30 Hrs [IST] Medtronic announced ...
Pharmabiz

Lundbeck announces last patient randomized ahead-of-schedule in phase 3 MASCOT clinical trial

H. Lundbeck A/S (Lundbeck), a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, announced that the last patient has been randomized ...
Pharmabiz

Ministry of Health issues draft amendment on testing norms for blood products

Ministry of Health issues draft amendment on testing norms for blood products: Our Bureau, New Delhi Wednesday, March 11, 2026, 12:50 Hrs [IST] The Ministry of Health and Family W ...
Pharmabiz

860 actions initiated based on risk-based inspections since December, 2022: Minister

The Central Drugs Standard Control Organisation (CDSCO), along with the State Drug Controllers have taken more than 860 actions based on the risk-based inspections conducted in more than 960 premises ...
Pharmabiz

Practo appoints former Union health secretary CK Mishra to its board of directors

Practo appoints former Union health secretary CK Mishra to its board of directors: Our Bureau, Bengaluru Wednesday, March 11, 2026, 11:45 Hrs [IST] Practo, India’s largest and m ...
Pharmabiz

Pfizer’s phase 2 study of trispecific antibody positive in moderate to severe atopic dermatitis

Pfizer’s phase 2 study of trispecific antibody positive in moderate to severe atopic dermatitis: New York Wednesday, March 11, 2026, 11:00 Hrs [IST] Pfizer Inc. announced positi ...
Pharmabiz

Singapore sets global first by reaching WHO’s highest classification for medical device regulation

The World Health Organization (WHO) announced that Singapore’s Health Sciences Authority (HSA) has achieved the highest level of regulatory performance for medical devices under WHO’s global ...